The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
Premium- AMAG Pharmaceuticals (NASDAQ:AMAG) announced this morning positive Phase III results for Feraheme as a treatment for anemia in the broad iron deficient population. Currently, this … Continue Reading
Read now- Vivus (NASDAQ:VVUS) announced FDA approval of its anti-obesity drug, Qsymia, last night and importantly, physicians can prescribe the medicine to patients without major restrictions. The … Continue Reading
Read now- In expectation of a takeover, Allos Therapeutics (NASDAQ:ALTH) is up 14% this morning off of yesterday afternoon’s plummet, but has yet to regain completely. Shareholders … Continue Reading
Read now- Stemcells, Inc (NASDAQ:STEM) is up 27% premarket on preclinical data showing improved memory and synaptic function in two animal models after transplantation of the company’s … Continue Reading
Read now- On July 9, QLT, Inc. (NASDAQ:QLTI) announced major changes to its business plan including the reduction of 146 employees, the planned departure of CEO Robert … Continue Reading
Read now- Johnson and Johnson (NYSE:JNJ) reported Q2 earnings this morning that were largely in-line with forecasts, although global sales fell short of expectations slightly at $16.48B. … Continue Reading
Read now- After reporting positive preliminary results for its lupus candidate, blisibimod, at the end of June, including a statistically significant improvement at week 20 vs. placebo … Continue Reading
Read now
